Related Experiment Videos
Bioresorbable polymeric stents: current status and future promise
Robert C Eberhart1, Shih-Horng Su, Kytai Truong Nguyen
1Department of Surgery, University of Texas Southwestern Medical Center at Dallas, 5323 Harry, Hines Boulevard, Dallas, TX 75390-9130, USA. robert.eberhart@utsouthwestern.edu
Journal of Biomaterials Science. Polymer Edition
|May 16, 2003
Summary
Bioresorbable polymeric stents offer a transient, biocompatible alternative to permanent metal stents for arterial disease treatment. This review highlights their development and advantages over traditional metallic implants.
Area of Science:
- Biomaterials Science
- Cardiovascular Engineering
- Medical Device Technology
Background:
- Metal stents are standard for arterial disease, stabilizing dissections and guiding vessel remodeling post-angioplasty.
- Polymer-coated metal stents enhance biocompatibility and drug delivery but remain permanent implants.
- Bioresorbable polymeric stents are emerging as a transient, potentially superior alternative.
Purpose of the Study:
- To review current metal stent technology for arterial interventions.
- To describe the development and characteristics of bioresorbable polymeric stents.
- To emphasize recent advancements in bioresorbable stent technology from the authors' research.
Main Methods:
- Review of existing literature on metal stent technology.
- Description of the design principles for expandable bioresorbable polymeric stents.
- Presentation of experimental data and findings on novel bioresorbable stent prototypes.
Main Results:
- Metal stents effectively manage arterial dissections but pose long-term challenges.
- Bioresorbable polymeric stents demonstrate potential for improved biocompatibility and transient support.
- The authors' laboratory has made significant progress in developing functional bioresorbable stent designs.
Conclusions:
- Bioresorbable polymeric stents represent a promising innovation in cardiovascular treatment.
- These stents offer a transient scaffold, potentially reducing complications associated with permanent metallic implants.
- Continued research and development are crucial for the clinical translation of bioresorbable stent technology.